PrimeRFP
PrimeRFP SCOUT · Federal Contract Recompete Brief

FA301625F0202Ordering 64 ARK fentanyl II reagent — Siemens Healthcare Diagnostics Inc

Siemens Healthcare Diagnostics Inc holds $112.7M across 924 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent N6264523D5013. PoP ended Sep 17, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fa3016 502 Cons Cl
Awarding office
Siemens Healthcare Diagnostics Inc
Recipient
Sep 17, 2025
PoP end
$112K
Obligated
$112K
Potential
325413
NAICS
6550
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Siemens Healthcare Diagnostics Inc — $90

Contract facts

Federal
Contract numberFA301625F0202
Also listed asFA3016-25-F-0202
Also listed asN6264523D5013-FA301625F0202
AgencyFa3016 502 Cons Cl
Awarding officeFa3016 502 Cons Cl
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentSiemens Healthcare Diagnostics Inc
CAGE1K2V6
UEIGC14SNHB3JN1
NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550
Parent IDIQ / IDVN6264523D5013
Place of performanceLACKLAND AFB TX
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startJun 18, 2025
PoP end (current)Sep 17, 2025
Obligated$112K
Current value$112K
Potential value$112K

ORDERING 64 ARK FENTANYL II REAGENT KITS FOR AF DRUG TESTING LABORATORY DELIVERY DATES:CLIN 0001 - 24JUN25 CLIN 0002 - 29JUL25CLIN 0003 - 26AUG25 CLIN 0004 - 09SEPT25ALL THE BASE IDIQ TERMS AND CONDITIONS APPLY TO THIS ORDER. is a federal award for Fa3016 502 Cons Cl held by Siemens Healthcare Diagnostics Inc. Estimated value $112K ($112K obligated). Current period of performance ends Sep 17, 2025. Place of performance: LACKLAND AFB TX.

ORDERING 64 ARK FENTANYL II REAGENT KITS FOR AF DRUG TESTING LABORATORY DELIVERY DATES:CLIN 0001 - 24JUN25 CLIN 0002 - 29JUL25CLIN 0003 - 26AUG25 CLIN 0004 - 09SEPT25ALL THE BASE IDIQ TERMS AND CONDITIONS APPLY TO THIS ORDER.

Recompete timing

Public
● Past PoP end (358 days ago)

Current PoP ended Sep 17, 2025 (358 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Siemens Healthcare Diagnostics Inc — $112.7M obligated across 924 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($112.7M) · all agencies
Department of Veterans Affairs (VA)$82.5M · 73%Department of Defense (DOD)$15.8M · 14%Department of Health and Human Services (HHS)$12.1M · 11%
Court Services and Offender Supervision Agency (CSOSA)$1.9M · 2%
Open full company profile →

Related awards

Same parent · incumbent
FA486121C0027
CONTRACT PROVIDES FOR THE LEASE OF IMMUNOASSAY / CHEMISTRY ANALYZER AND ASSOCIATED ANCILLA…
$4.1M
Sep 14, 2026
75H71121P00111
PURHCASE ORDER FOR COST PER TEST AGREEMENT FOR CLINTON, WEWOKA, LAWTON AND CLAREMORE LABOR…
$7.0M
Sep 30, 2026
75H71220C00017
OY1, PIMC
$1.4M
Sep 30, 2026
36C24626N0011
CHEMISTRY IMMUNOASSAY CPRR: ADD RENTAL SEALERS AND CONSUMABLES FOR THE SEALERS.
$1.3M
Sep 30, 2026
36C24226N0141
CHEMISTRY AND IMMUNOCHEMISTRY CPRR TESTING, SUPPLIES AND MAINTENANCE
$990K
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract FA301625F0202?

FA301625F0202 (Ordering 64 ARK fentanyl II reagent) is a Fa3016 502 Cons Cl award with a potential value of $112K, currently held by Siemens Healthcare Diagnostics Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is FA3016-25-F-0202?

FA3016-25-F-0202 is the dashed form of PIID FA301625F0202 (Ordering 64 ARK fentanyl II reagent), held by Siemens Healthcare Diagnostics Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded FA301625F0202?

Fa3016 502 Cons Cl awarded FA301625F0202 to Siemens Healthcare Diagnostics Inc (potential $112K).

Who is the incumbent on FA301625F0202?

Siemens Healthcare Diagnostics Inc is the incumbent with $112.7M across 924 related awards in SCOUT’s public footprint. The current period of performance ends Sep 17, 2025.

When does Siemens Healthcare Diagnostics Inc’s FA301625F0202 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 17, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on FA301625F0202 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/FA301625F0202